Read E.V.I.dently Today for current news about health policy and events, among other topics.
E.V.I.dently Today Blog
New research from Tufts Medical Center and the National Pharmaceutical Council indicates that patient access to therapies depends on factors other than cost and clinical benefit.
National Pharmaceutical Council in STAT: The (relative) risk in misinterpreting health spending statistics
National Pharmaceutical Council Chief Science Officer and Executive Vice President Robert W. Dubois, MD, PhD, explains in his column in STAT that the absolute numbers tell a different story than the headlines about health care spending. Dr. Dubois provides context and analysis for recent health spending numbers, and suggests that complex health policy questions can't be solved until we back away from comfortable — and misleading — relative risk narratives.
National health care spending is expected to increase to $5.7 trillion and comprise nearly 20% of the Gross Domestic Product by 2026, according to the latest statistics reported today by the Centers for Medicare and Medicaid Services. National Pharmaceutical Council Chief Science Officer Robert Dubois, MD, PhD, said that spending more on health care does not mean that we are spending our dollars well.
The Health Affairs and National Pharmaceutical Council event, “Health Spending: Tackling the Big Issues,” convened a crowd of more than 450 to ask critical questions about how the United States invests its health dollars – more than $3 trillion in spending a year – and what information is needed to help make those investments more wisely.
New research from the Department of Pharmaceutical Health Services Research at the University of Maryland School of Pharmacy and the National Pharmaceutical Council reveals that real-world evidence (RWE) is considered valuable by the editors of peer-reviewed journals—if it meets certain criteria for quality.
In his latest column for the American Journal of Pharmacy Benefits, National Pharmaceutical Council President Dan Leonard argues it’s time for us to have a broader, more honest conversation about health care spending.